Literature DB >> 26352388

The influence of a six-week, high-intensity games intervention on the pulmonary oxygen uptake kinetics in prepubertal obese and normal-weight children.

Melitta A McNarry1, Danielle Lambrick2, Nicole Westrupp3, James Faulkner4.   

Abstract

The pulmonary oxygen uptake response is deleteriously influenced by obesity in prepubertal children, as evidenced by a slower phase II response. To date, no studies have investigated the ability of an exercise intervention to ameliorate this. The objective of the study was to investigate the influence of a 6-week, high-intensity, games-orientated intervention on the oxygen uptake kinetic response of prepubertal obese and normal-weight children during heavy-intensity exercise. Thirteen normal-weight and 15 obese children participated in a twice-weekly exercise intervention involving repeated bouts of 6-min high-intensity, games-orientated exercises followed by 2 min of recovery. Sixteen normal-weight and 11 obese children served as a control group. At baseline and post-intervention, each participant completed a graded-exercise test to volitional exhaustion and constant work-rate, heavy-intensity exercise. Post-intervention, obese children demonstrated a reduced phase II τ (pre-intervention: 30 ± 8 cf. post-intervention: 24 ± 7 s), mean response time (pre-intervention: 50 ± 10 cf. post-intervention: 38 ± 9 s) and phase II amplitude (pre-intervention: 1.51 ± 0.30 cf. post-intervention: 1.34 ± 0.27 L·min(-1)). No changes were evident in the normal-weight children. In conclusion, the present findings demonstrate that a 6-week, high-intensity intervention can have a significant positive impact on the dynamic oxygen uptake response of obese prepubertal children.

Entities:  

Keywords:  BMI; IMC; V̇O2 kinetics; cinétique du O2; entraînement; exercise intensity; games; high intensity; intensité de l’exercice; intensité élevée; jeux; training

Mesh:

Year:  2015        PMID: 26352388     DOI: 10.1139/apnm-2015-0051

Source DB:  PubMed          Journal:  Appl Physiol Nutr Metab        ISSN: 1715-5312            Impact factor:   2.665


  6 in total

1.  Exercise and Cardiovascular Disease Risk Factors in Children and Adolescents With Obesity: A Systematic Review With Meta-Analysis of Randomized Controlled Trials.

Authors:  George A Kelley; Kristi S Kelley; Russell R Pate
Journal:  Am J Lifestyle Med       Date:  2021-02-19

Review 2.  Feasibility of incorporating high-intensity interval training into physical education programs to improve body composition and cardiorespiratory capacity of overweight and obese children: A systematic review.

Authors:  Pedro Delgado-Floody; Pedro Latorre-Román; Daniel Jerez-Mayorga; Felipe Caamaño-Navarrete; Felipe García-Pinillos
Journal:  J Exerc Sci Fit       Date:  2018-11-15       Impact factor: 3.103

3.  School-based high-intensity interval training programs in children and adolescents: A systematic review and meta-analysis.

Authors:  Stephanie L Duncombe; Alan R Barker; Bert Bond; Renae Earle; Jo Varley-Campbell; Dimitris Vlachopoulos; Jacqueline L Walker; Kathryn L Weston; Michalis Stylianou
Journal:  PLoS One       Date:  2022-05-04       Impact factor: 3.752

4.  Heart rate and gas exchange dynamic responses to multiple brief exercise bouts (MBEB) in early- and late-pubertal boys and girls.

Authors:  Ronen Bar-Yoseph; Shlomit Radom-Aizik; Nicholas Coronato; Nazanin Moradinasab; Thomas J Barstow; Annamarie Stehli; Don Brown; Dan M Cooper
Journal:  Physiol Rep       Date:  2022-08

5.  Exercise and adiposity in overweight and obese children and adolescents: a systematic review with network meta-analysis of randomised trials.

Authors:  George A Kelley; Kristi S Kelley; Russell R Pate
Journal:  BMJ Open       Date:  2019-11-11       Impact factor: 2.692

6.  Normal Weight 6-12 Years Boys Demonstrate Better Cognitive Function and Aerobic Fitness Compared to Overweight Peers.

Authors:  Vaida Borkertienė; Laura Valonytė-Burneikienė
Journal:  Medicina (Kaunas)       Date:  2022-03-14       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.